As one FDA initiative works to sustain the momentum of rare disease research, other events threaten to slow progress.

An investigation by Democratic senators has raised concerns about conflicts of interest in telehealth companies' ties to ...

Taking a page from Eli Lilly and Novo Nordisk, who have launched online programs to sell their diabetes and obesity drugs ...

Overview of Nanotechnology Drug Delivery MarketThe global Nanotechnology Drug Delivery Market is valued at USD 97.98 Billion ...

Treatments for bronchiectasis, chronic immune thrombocytopenia, fibromyalgia, Friedreich ataxia, and recurrent respiratory papillomatosis are under review.

Discover the current pipeline candidates advancing through the clinic for the treatment of sickle cell disease.

Johnson & Johnson (NYSE:JNJ) announced on Thursday that the U.S. FDA granted priority review for its new drug application aimed at getting marketing approval for TAR-200, a drug-releasing system for ...

With the rise of advanced simulation and model-informed drug development (MIDD) techniques like digital twins, researchers ...

The program is the latest example of pharmaceutical companies bypassing traditional drug distribution channels for people who ...

A recalled sickle cell drug is drawing new scrutiny from attorneys who say it may have done more harm than good, possibly ...

Biohaven’s valuation has dropped from $3.9B to $1.42B, but no revenue and high cash burn still limit its appeal. Read why ...

But benzathine penicillin G is the only product that’s approved and recommended to treat the sexually transmitted infection syphilis during pregnancy. If the infection is caught early, a single ...